Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Oncol ; 36(3): 215-6, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25265358

ABSTRACT

BACKGROUND: One of the malignant tumors among head and neck cancers is nasopharyngeal carcinoma. Many studies consider human papilloma virus (HPV) as a cause for nasopharyngeal carcinoma. METHODS: 41 paraffin-wax-embedded block samples were examined to detect HPV DNA and its subtype's presence by polymerase chain reaction. The recurrence, prognosis and survival were evaluated for an average of 48 months. RESULTS: HPV DNA was positive in 9 patients (22%). The overall recurrence rate was 75% in HPV negative patients and 11% in HPV positive ones. The mortality rate in HPV negative and positive patients was 37.5% and 0%, respectively. CONCLUSION: HPV type 18 and 16 were the most common subtypes. Also, it can be implied that patients which are HPV positive had better prognosis and also less recurrence.


Subject(s)
Carcinoma, Squamous Cell/mortality , Nasopharyngeal Neoplasms/mortality , Neoplasm Recurrence, Local/mortality , Papillomaviridae/isolation & purification , Papillomavirus Infections/mortality , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Carcinoma, Squamous Cell/virology , Chemoradiotherapy , DNA, Viral/genetics , Female , Follow-Up Studies , Humans , Male , Middle Aged , Nasopharyngeal Carcinoma , Nasopharyngeal Neoplasms/pathology , Nasopharyngeal Neoplasms/therapy , Nasopharyngeal Neoplasms/virology , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/therapy , Neoplasm Recurrence, Local/virology , Neoplasm Staging , Papillomaviridae/genetics , Papillomavirus Infections/pathology , Papillomavirus Infections/therapy , Papillomavirus Infections/virology , Polymerase Chain Reaction , Prognosis , Survival Rate , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...